Kura Oncology Inc (NASDAQ:KURA)

20.25
Delayed Data
As of Sep 24
 -0.10 / -0.49%
Today’s Change
15.12
Today|||52-Week Range
43.00
-38.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.0K--0.000.00
 
 
 
Operating ExpensesGross Income-1.0K0.000.000.00
 
 
General Expenses16.0M16.6M15.0M15.9M
 
 
 
 
 
Research And Development11.7M12.1M10.4M11.4M
 
 
 
 
 
Total Operating Expenses16.0M16.6M15.0M15.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.0M-16.6M-15.0M-15.9M
 
 
 
 
 
Extraordinary Charge0.00-498.0K0.000.00
 
 
Interest Expense On Debt252.0K193.0K145.0K148.0K
 
 
 
 
 
Other Expenses180.0K180.0K126.0K74.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.0M-16.1M-13.9M-14.9M
 
 
 
 
 
Net Income-15.0M-16.1M-13.9M-14.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.8M38.1M38.2M38.9M
 
 
 
 
 
Shares To Calculate EPS Diluted37.8M38.1M38.2M38.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.40-$0.42-$0.37-$0.38
 
 
 
 
 
EPS Diluted-$0.40-$0.42-$0.37-$0.38